Genprex S-1 IPO, KSK Oil, Muscle Maker Reg A+ IPO, Blood Cancer TreatmentBlog
RodTurner's blog Genprex (S-1 IPO) expects to list on the NASDAQ on Friday March 16 th- two days left. Their Oncoprex medicine delivers DNA to lung cancer cells via custom nanoparticles and causes low ...